论文部分内容阅读
美国ＦＤＡ近期批准了ＮｏｖｏＮｏｒｄｉｓｋ公司的激素替代治疗（ＨＲＴ）复方产品Ａｃｔｉｖ－ｅｌｅ用于治疗绝经所致血管舒缩症状及阴门和阴道萎缩，它有望于１９９９年第一季度在美国上市。Ａｃｔｉｖｅｌｅ自首次在欧盟获准上市后，已陆续在瑞典、德国和英国上市，...
US FDA recently approved NovoNordisk’s hormone replacement therapy (HRT) compound Activ-ele for the treatment of menopausal symptoms of vasomotor and vaginal and vaginal atrophy, which is expected to be available in the United States in the first quarter of 1999. Activele has been listed in Sweden, Germany and the United Kingdom since its first listing in the EU, ...